Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

The cyclin-dependent kinase inhibitor p27Kip1 has been suggested as a prognostic marker in prostate cancer. The aim of this study was to determine the clinical and prognostic role of p27 expression in hormone-naive prostate cancers. A tissue microarray containing samples from 4,699 prostate cancers...

Descripción completa

Detalles Bibliográficos
Autores principales: SIRMA, HÜSEYIN, BROEMEL, MARGARETHE, STUMM, LAURA, TSOURLAKIS, TINA, STEURER, STEFAN, TENNSTEDT, PIERRE, SALOMON, GEORG, MICHL, UWE, HAESE, ALEXANDER, SIMON, RONALD, SAUTER, GUIDO, SCHLOMM, THORSTEN, MINNER, SARAH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813765/
https://www.ncbi.nlm.nih.gov/pubmed/24179503
http://dx.doi.org/10.3892/ol.2013.1563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813765/
https://www.ncbi.nlm.nih.gov/pubmed/24179503
http://dx.doi.org/10.3892/ol.2013.1563

Ejemplares similares